CYP27B1 polymorphisms variants are associated with type 1 diabetes mellitus in Germans

Journal of Steroid Biochemistry and Molecular Biology

Volumn 89-90, Issue , 2004, Pages 155-157

  Lopez, Elizabeth Ramos ^a   Regulla, Karoline ^a   Pani, Michael A ^a   Krause, Maren ^a   Usadel, Klaus H ^a   Badenhoop, Klaus ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

CYP27B1 polymorphisms; Diabetes mellitus type 1; Vitamin D

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE;

ADOLESCENT; ADULT; ALLELE; CHILD; CHROMOSOME 12Q; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRON; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; CHROMOSOMES, HUMAN, PAIR 12; DIABETES MELLITUS, TYPE 1; GERMANY; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

ANIMALIA;

EID: 3042596823     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.03.095     Document Type: Conference Paper

References (20)

1. Mathieu C., Waer M., Laureys J., Rutgeerts O., Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1, 25 dihydroxyvitamin D. Diabetologia. 37:1994;552-558
2. Fournier C., Gepner P., Sadouk M., Charreire J. In vivo beneficial effects of cyclosporin A and 1, 25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis. Clin. Immunol. Immunopathol. 54:1990;53-63
3. Lemire J.M., Archer D.C. 1, 25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J. Clin. Invest. 87:1991;1103-1107
4. Hahn H.J., Kuttler B., Mathieu C., Bouillon R. 1, 25-Dihydroxyvitamin D3 reduces MHC antigen expression on pancreatic beta-cells in vitro. Transplant. Proc. 29:1997;2156-2157
5. Thomasset M. Vitamin D and the immune system. Pathol. Biol. (Paris). 42:1994;163-172
6. Atkinson M.A., Maclaren N.K. The pathogenesis of insulin-dependent diabetes. N. Engl. J. Med. 331:1994;1428-1436
7. J. Nerup, P. Platz, O.O. Anderseen, HLA antigens and diabetes mellitus, Lancet (1974) 864-866.
8. Nistico L., Buzzetti R., Pritchard L.E., Van der Auwera B., Giovannini C., Bosi E., Larrad M.T., Rios M.S., Chow C.C., Cockram C.S., Jakobs K., Mijovic C., Bain S.C., Barnett A.H., Vandewalle C.L., Schuit F., Gorus F.K., Reg B.D., Rosi R., Pozzili P., Todd J.A. The CTLA-4 gene region on chromosome 2q33 is linked to, and associated with type 1 diabetes. Hum. Mol. Genet. 5:1996;1075-1080
9. Pani M.A., Knapp M., Donner H., Braun J., Baur M.P., Usadel K.H., Badenhoop K. Vitamin D receptor allele combinations influence genetic susceptibility to type I diabetes in Germans. Diabetes. 49:2000;504-507
10. Hypponen E., Laara E., Reunanen A., Jarvelin M.R., Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 358:2001;1500-1503
11. Paulson S.K., Deluca H.F. Subcellular location and properties of rat renal 25-hydroxyvitamin D3-1 alpha-hydroxylase. J. Biol. Chem. 260:1985;11488-11492
12. Zehnder D., Bland R., Walker E.A., Bradwell A.R., Howie A.J., Hewison M., Stewart P.M. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney. J. Am. Soc. Nephrol. 10:2000;2465-2473
13. Zehnder D., Bland R., Williams M.C., McNinch R.W., Howie A.J., Stewart P.M., Hewison M. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin. Endocrinol. Metab. 86:2001;888-894
14. Miller W.L., Portale A.A. Vitamin D 1alpha-hydroxylase. Trends Endocrinol. Metab. 11:2000;315-319
15. Kong X.F., Zhu X.H., Pei Y.L., Jackson D.M., Holick M.F. Molecular cloning, characterization, and promoter analysis of the human 25-hydroxyvitamin D3-1alpha-hydroxylase gene. Proc. Natl. Acad. Sci. U.S.A. 96:1999;6988-6993
16. Smith S.J., Rucka A.K., Berry J.L., Davies M., Mylchreest S., Paterson C.R., Heath D.A., Tassabehji M., Read A.P., Mee A.P., Mawer E.B. Novel mutations in the 1alpha-hydroxylase (P450c1) gene in three families with pseudovitamin D-deficiency rickets resulting in loss of functional enzyme activity in blood-derived macrophages. J. Bone Miner. Res. 14:1999;730-739
17. Shan P.C., Curtis D. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Am. J. Hum. Genet. 59:1995;323-336
18. Hawkins G.A., Cramer S.D., Zheng S.L., Isaacs S.D., Wiley K.E., Chang B.L., Bleecker E.R., Walsh P.C., Meyers D.A., Isaacs W.B., Xu J. Sequence variants in the human 25-hydroxyvitamin D3 1-alpha-hydroxylase (CYP27B1) gene are not associated with prostate cancer risk. Prostate. 53:2002;175-178
19. Bareis P., Bises G., Bischof M.G., Manhardt T., Bland R., Cross H.S., Peterlik M. 25-hydroxy-vitamin D metabolism in human colon cancer cells during tumor progression. Biochem. Biophys. Res. Commun. 285:2001;1012-1017
20. Dardenne O., Prud'homme O.J., Arabian A., Glorieux F.H., St-Arnaud R. Targeted Inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology. 142:2001;3135-3141